Application of interferon modulators to overcome partial resistance of human ovarian cancers to VSV-GP oncolytic viral therapy.

Dold, Catherine; Rodriguez Urbiola, Carles; Wollmann, Guido; Egerer, Lisa; Muik, Alexander; Bellmann, Lydia; Fiegl, Heidelinde; Marth, Christian; Kimpel, Janine; von Laer, Dorothee.

Afiliação

Dold C; Division of Virology, Medical University of Innsbruck , Innsbruck, Austria.
Rodriguez Urbiola C; Division of Virology, Medical University of Innsbruck , Innsbruck, Austria.
Wollmann G; Division of Virology, Medical University of Innsbruck , Innsbruck, Austria.
Egerer L; Division of Virology, Medical University of Innsbruck , Innsbruck, Austria.
Muik A; Applied Virology and Gene Therapy Unit , Frankfurt am Main, Germany.
Bellmann L; Division of Virology, Medical University of Innsbruck , Innsbruck, Austria.
Fiegl H; Department of Gynecology and Obstetrics, Medical University of Innsbruck , Innsbruck, Austria.
Marth C; Department of Gynecology and Obstetrics, Medical University of Innsbruck , Innsbruck, Austria.
Kimpel J; Division of Virology, Medical University of Innsbruck , Innsbruck, Austria.
von Laer D; Division of Virology, Medical University of Innsbruck , Innsbruck, Austria.

Mol Ther Oncolytics ; 3: 16021, 2016.

Article em En | MEDLINE | ID: mdl-27738655

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2016 Tipo de documento: Article